Antithrombin to prevent blood clots after serious trauma
Part of Heart & circulation, Injuries & trauma clinical trials.
This Phase 2 trial studies whether giving antithrombin can better prevent harmful blood clots (venous thromboembolism) after serious injuries. The goal is to reduce clot risk while you’re in the trauma ICU or step-down unit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are admitted to the trauma team (for serious injury).
- You have multiple injuries or a pelvic or long-bone fracture.
- You expect to be cared for in the trauma ICU or a step-down unit.
- You (or your legal representative) can give informed consent.
- You must not be in another treatment study at the same time (unless the trial doctor approves).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a higher dose of a blood thinner (enoxaparin) works better than the standard dose to prevent dangerous blood clots in the legs or lungs after a severe injury. It is for adults in the intensive care unit who are expected to stay more than 48 hours.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can improve outcomes for children with certain serious head or torso injuries. It aims to reduce complications from internal bleeding when the medicine is given soon after the injury.
This trial compares giving whole blood versus standard care in adults with severe trauma and dangerous blood loss (hemorrhagic shock). The goal is to see if whole blood helps stabilize patients faster and improves outcomes after major bleeding.
This trial tests a treatment called INTERCEPT Fibrinogen Complex (IFC) to help control bleeding in trauma patients. It is given to patients who arrive at the hospital quickly after injury and have low fibrinogen levels.
This trial is testing a new way to give blood thinners to people who have been in a serious accident. The goal is to see if adjusting the dose based on your blood levels helps prevent dangerous blood clots.
This trial tests whether taking an anti–blood clot medicine (dalteparin) and using leg compression can reduce dangerous blood clots after a severe traumatic brain injury. It may help lower the chance of clots forming when people are immobile and at higher risk.
Hear when a new Trauma Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.